PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2004
PHARMANIAGA BERHAD |
Quarterly report for the financial period ended | 30/06/2004 |
Quarter | 2 |
Financial Year End | 31/12/2004 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2004 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2004 | 30/06/2003 | 30/06/2004 | 30/06/2003 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 178,644 | 155,262 | 369,949 | 309,787 |
2 | Profit/(loss) before tax | 16,264 | 13,347 | 36,933 | 31,260 |
3 | Profit/(loss) after tax and minority interest | 10,882 | 8,389 | 23,266 | 20,035 |
4 | Net profit/(loss) for the period | 10,882 | 8,389 | 23,266 | 20,035 |
5 | Basic earnings/(loss) per share (sen) | 10.77 | 8.39 | 23.05 | 20.03 |
6 | Dividend per share (sen) | 4.50 | 3.50 | 4.50 | 3.50 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net tangible assets per share (RM) | 2.3800 | 2.2200 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Remarks : |
The Board of Directors of Pharmaniaga Berhad recommends an interim tax exempt dividend of 4.5 sen per share (2003: tax exempt dividend of 3.5 sen per share). The dates of entitlement and payment will be announced at a later date. |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 6 Aug 2004 |
Category | Financial Results |
Reference No | CC-040803-62728 |